Cancer Drugs: Strong Growth for Bristol’s Opdivo, Pfizer’s Ibrance
December 30, 2015 at 12:17 PM EST
November sales data for cancer drugs is out, and according to Morgan Stanley analyst David Risinger , “a picture is worth a thousand words.” READ MORE »
